7 Stocks Under $10 Making Big Moves

As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Stocks that are in favor and making large moves is a segment of the market that I tweet about on a regular basis.These are also the exact type of stocks that I love to trade and alert to my subscribers in real-time.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Catalyst Biosciences

  • Thursday's Range: $1.51-$1.99
  • 52-Week Range: $1.30-$21.60
  • Thursday's Volume: 260,000
  • Three-Month Average Volume: 26,575

Catalyst Biosciences  (CBIO) , a clinical-stage biopharmaceutical company, focuses on engineering proteases as therapeutics for hemophilia, hemeostasis, complement-mediated diseases and other unmet medical needs. This stock traded up 21% to $1.88 in Thursday's trading session.

From a technical perspective, Catalyst Biosciences exploded higher on Thursday right off its 20-day moving average of $1.50 a share and off its 50-day moving average of $1.53 a share with strong upside volume flows. This high-volume rip to the upside pushed this stock into breakout territory, since shares of Catalyst Biosciences managed to take out some near-term overhead resistance levels at $1.66 to $1.83 a share. That move is now quickly pushing this stock within range of triggering another big breakout trade. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $2 to $2.16 a share with high volume.

Traders should now look for long-biased trades in Catalyst Biosciences as long as it's trending above $1.66 a share and then once it sustains a move or close above those breakout levels with volume that registers near or above 26,575 shares. If that breakout triggers soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $2.40 to $2.80, or even $3 to its 200-day moving average of $3.25 a share.

Cadiz

  • Thursday's Range: $5.90-$6.31
  • 52-Week Range: $2.71-$10.50
  • Thursday's Volume: 42,000
  • Three-Month Average Volume: 65,147

Cadiz  (CDZI)  operates as a land and water resource development company in the U.S. This stock closed up 6.5% to $5.89 in Thursday's trading session.

From a technical perspective, Cadiz ripped sharply higher on Thursday right above its 50-day moving average of $5.81 a share and back above its 20-day moving average of $6.06 a share with lighter-than-average volume. This jump to the upside is now quickly pushing shares of Cadiz within range of triggering a near-term breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $6.31 to $6.40 a share and then above more key resistance at $6.67 a share with high volume.

Traders should now look for long-biased trades in Cadiz as long as it's trending above its 20-day moving average of $6.06 a share or above Thursday's intraday low of $5.90 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 65,147 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $7 to $7.66 a share.

Global Eagle Entertainment

  • Thursday's Range: $7.16-$7.48
  • 52-Week Range: $6.52-$14.40
  • Thursday's Volume: 243,000
  • Three-Month Average Volume: 370,222

Global Eagle Entertainment (ENT)  provides content, connectivity and digital media solutions for travel industry worldwide. This stock traded up 1.9% to $7.47 in Thursday's trading session.

From a technical perspective, Global Eagle Entertainment spiked modestly higher on Thursday right off its 20-day moving average of $7.22 a share with lighter-than-average volume. This stock has been uptrending over the last few weeks, with shares moving higher off its low of $6.52 a share to its recent high of $7.54 a share. During that uptrend, shares of Global Eagle Entertainment have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed this stock within range of triggering a big breakout trade. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $7.54 to $7.75 a share and then above its 50-day moving average of $7.90 to $8 a share with high volume.

Traders should now look for long-biased trades in Global Eagle Entertainment as long as it's trending above some near-term support at $7.16 a share then once it sustains a move or close above those breakout levels with volume that hits near or above 370,222 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $8.70 to $9, or even $9.50 to $9.85 a share.

Cesca Therapeutics

  • Thursday's Range: $2.89-$3.78
  • 52-Week Range: $1.60-$21.80
  • Thursday's Volume: 1.80 million
  • Three-Month Average Volume: 227,259

Cesca Therapeutics  (KOOL)  focuses on the research, development and commercialization of autologous cell-based therapeutics for use in regenerative medicine in the U.S. and internationally. This stock traded up 20.7% to $3.67 in Thursday's trading session.

From a technical perspective, Cesca Therapeutics exploded higher on Thursday right off its 20-day moving average of $2.89 a share and back above its 50-day moving average of $3.04 a share with strong upside volume flows. Market players should now look for a continuation move to the upside in the short-term if shares of Cesca Therapeutics manages to take out Thursday's intraday high of $3.78 a share with strong upside volume flows.

Traders should now look for long-biased trades in Cesca Therapeutics as long as it's trending above $3.45 a share or above $3.20 a share and then once it sustains a move or close above Thursday's intraday high of $3.78 a share with volume that hits near or above 227,259 shares. If that move gets underway soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $4.30 to $4.45, or even $5 to $5.80 a share.

Arcadia Biosciences

  • Thursday's Range: $1.43-$1.55
  • 52-Week Range: $1.10-$8.80
  • Thursday's Volume: 25,000
  • Three-Month Average Volume: 29,778

Arcadia Biosciences  (RKDA) , an agricultural biotechnology trait company, provides late-stage crop productivity and product quality traits for various crops in the food and feed markets worldwide. This stock traded up 3.3% to $1.55 in Thursday's trading session.

From a technical perspective, Arcadia Biosciences spiked notably higher on Thursday right off its 20-day moving average of $1.46 a share with decent upside volume flows. This bump to the upside is now quickly pushing shares of Arcadia Biosciences within range of triggering a breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at Thursday's intraday high of $1.57 a share and then once it clears more key resistance at $1.61 a share with high volume.

Traders should now look for long-biased trades in Arcadia Biosciences as long as it's trending above its 20-day moving average of $1.46 a share or above more near-term support at $1.37 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 29,778 shares. If that breakout materializes soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $1.85 to $2, or its 50-day moving average of $2.03 to $2.20 a share.

Klondex Mines

  • Thursday's Range: $3.47-$3.67
  • 52-Week Range: $1.76-$3.87
  • Thursday's Volume: 213,000
  • Three-Month Average Volume: 196,408

Klondex Mines  (KLDX) , together with its subsidiaries, acquires, explores, develops and produces mineral properties in Nevada. This stock traded up 4.2% to $3.65 in Thursday's trading session.

From a technical perspective, Klondex Mines ripped sharply higher on Thursday right off its 20-day moving average of $3.49 a share with above-average volume. This high-volume rip to the upside pushed this stock into breakout territory, since shares of Klondex Mines took out some near-term overhead resistance at $3.57 a share. That move is now quickly pushing this stock within range of triggering a much bigger breakout trade. That trade will trigger if this stock manages to clear some near-term overhead resistance levels at $3.70 to $3.78 a share and then above its 52-week high of $3.87 a share with high volume.

Traders should now look for long-biased trades in Klondex Mines as long as it's trending above its 20-day moving average of $3.49 a share or above its 50-day moving average of $3.37 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 196,408 shares. If that breakout develops soon, then this stock will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $4.50 to $5 a share.

Marrone Bio Innovations

  • Thursday's Range: $0.69-$0.75
  • 52-Week Range: $0.60-$4.00
  • Thursday's Volume: 332,000
  • Three-Month Average Volume: 40,642

Marrone Bio Innovations  (MBII)  provides bio-based pest management and plant health products primarily for agricultural and water markets in the U.S. and internationally. This stock traded up 5.7% to 74 cents per share in Thursday's trading session.

From a technical perspective, Marrone Bio Innovations spiked notably higher on Thursday right off its 20-day moving average of 69 cents per share with strong upside volume flows. This high-volume jump to the upside is now quickly pushing shares of Marrone Bio Innovations within range of triggering a near-term breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out some near-term resistance levels at 75 cents to its 50-day moving average of 76 cents per share and then above more resistance at 80 cents per share with high volume.

Traders should now look for long-biased trades in Marrone Bio Innovations as long as it's trending above its 20-day moving average of 69 cents per share or above more near-term support at 64 cents per share and then once it sustains a move or close above those breakout levels with volume that hits near or above 40,642 shares. If that breakout takes hold soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at 90 to 91 cents, or even $1 to $1.20 a share.

Disclosure: This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.

More from Opinion

The Good, the Bad, and the Unknowns of AI and Apple Watches

The Good, the Bad, and the Unknowns of AI and Apple Watches

Flashback Friday: Bye Bye FAANG

Flashback Friday: Bye Bye FAANG

Micron Slumps After Issuing Light Guidance: 7 Key Takeaways

Micron Slumps After Issuing Light Guidance: 7 Key Takeaways

Throwback Thursday: Let's Talk Tilray

Throwback Thursday: Let's Talk Tilray

Amazon's Reported Plans to Greatly Expand Its Cashier-Free Stores: 5 Takeaways

Amazon's Reported Plans to Greatly Expand Its Cashier-Free Stores: 5 Takeaways